Omiloxetine (INN) is an antidepressant with a similar chemical structure to that of paroxetine which either was or is still under development by Ferrer Internacional for the treatment of major depression. It acts as a highly selective serotonin reuptake inhibitor (SSRI) and is said to possess a greater degree of selectivity for serotonin reuptake over dopamine and norepinephrine reuptake compared to other SSRIs.
This page contains content from the copyrighted Wikipedia article "Omiloxetine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
